Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pfizer Ltd. Regulatory Filings 2025

Dec 28, 2025

60507_rns_2025-12-28_1c2661d9-e57b-4d47-87bf-5543d5cd35bb.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [100 x 42] intentionally omitted <==

Pfizer Limited

The Capital, 1802/1901, Plot No. C - 70, G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400 051. Tel : +91 22 6693 2000 Fax : +91 22 2654 0274

December 28, 2025

The Corporate Relationship Dept. The Manager, Listing Dept. BSE Limited The National Stock Exchange of India Ltd. 1[st] Floor, P.J.Towers Exchange Plaza, 5[th] Floor, Plot No. C/1, Dalal Street, Fort G Block Bandra-Kurla Complex, Bandra (E) Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 500680 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015.

Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Company has received an Order dated December 27, 2025, issued by Office of the Additional Commissioner of GST & CX, Jurisdiction: Kolkata, West Bengal basis the GST audit conducted for the state of West Bengal for FY 2018-19 to FY 2022-23, for a Tax demand of Rs. 4,39,55,698/- and a penalty of Rs. 4,39,55,698/- aggregating to a total demand of Rs. 8,79,11,396/- plus applicable interest .

Based on the Company’s assessment, the Company believes that the said demand is not maintainable. The Company is in the process of preferring an appeal against the said Order. The Order has no material impact on the financials, operations or other activities of the Company.

The additional details required to be disclosed pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, is enclosed as Annexure A.

Request you to please take the above on record.

Thanking you,

Yours truly, For Pfizer Limited Prajeet Digitally signed by Prajeet Nair Nair Date: 2025.12.28 12:26:08 +05'30' Prajeet Nair

Director – Corporate Services & Company Secretary

CIN: L24231MH1950PLC008311 Email ID: [email protected] Website: www.pfizerltd.co.in

Annexure A

Additional information pursuant to SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024

Sr.No. Particulars Details
1 Name of Authority AdditionalCommissionerofGST&CX,Jurisdiction : Kolkata, West Bengal
2 Nature and details of the action(s)taken or order(s) passed The Order is received under section 74 of Goods &Services Tax Act, 2017 for a Tax demand ofRs. 4,39,55,698/- (Rupees Four Crore Thirty NineLakh Fifty Five Thousand Six Hundred and NinetyEight) and a penalty of Rs. 4,39,55,698/- (RupeesFour Crore Thirty Nine Lakh Fifty Five Thousand SixHundred and Ninety Eight) aggregating to a totaldemand of Rs. 8,79,11,396/- (Rupees Eight CroreSeventy Nine Lakh Eleven Thousand ThreeHundred Ninety Six) plus applicable interest.
3 Date of receipt of direction or order December 27, 2025
4 Detailsoftheviolation(s)/contravention(s)committedoralleged to be committed The Additional Commissioner has raised the GSTdemand and penalty alleging incorrect availmentof Input Tax Credit by the Company for theFinancial Years 2018-19 to 2022-23.
5 Impact on financial, operation orother activities of the listed entity,quantifiable in monetary terms tothe extent possible Based on our assessment, we believe that the saiddemand is not maintainable, and the Company is inthe process of preferring an appeal against the saidOrder.The Order has no material impact on the financials,operations or other activities of the Company.